Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma, Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03829501
What this trial is testing

A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies

Who this might be right for
Squamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more
Kymab Limited 222
Testing effectiveness (Phase 2)Active Not RecruitingNCT04205227
What this trial is testing

ENB003 Plus Pembrolizumab Phase 1b/2a in Solid Tumors

Who this might be right for
CancerMelanomaOvary Cancer+2 more
ENB Therapeutics, Inc 137
Not applicableLooking for participantsNCT06753136
What this trial is testing

Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype

Who this might be right for
Primary Visceral Tumors of Any HistotypeVisceral LesionsLiver Cancer+9 more
Istituto Oncologico Veneto IRCCS 24
Early research (Phase 1)Ended earlyNCT01216436
What this trial is testing

Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Duke University 2
Testing effectiveness (Phase 2)WithdrawnNCT03327064
What this trial is testing

A Biomarker Evaluation Trial of UAB30 in Renal Transplant Recipients at High Risk for Non-melanoma Skin Cancer

Who this might be right for
Non-melanoma Skin Cancer
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Ended earlyNCT01350401
What this trial is testing

Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma

Who this might be right for
Melanoma
Adaptimmune 4
Testing effectiveness (Phase 2)WithdrawnNCT01764009
What this trial is testing

Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Valerio Therapeutics
Not applicableStudy completedNCT01986712
What this trial is testing

Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
St. Luke's Hospital and Health Network, Pennsylvania 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02938299
What this trial is testing

Neoadjuvant L19IL2/L19TNF- Pivotal Study

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 214
Not applicableLooking for participantsNCT04424719
What this trial is testing

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

Who this might be right for
Uveal Melanoma
Institut Curie 700
Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Large-scale testing (Phase 3)Study completedNCT03635983
What this trial is testing

NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 783
Early research (Phase 1)Study completedNCT01436656
What this trial is testing

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

Who this might be right for
Melanoma and Metastatic Colorectal Cancer
Pfizer 107
Early research (Phase 1)Ended earlyNCT01950195
What this trial is testing

SRS (Stereotactic Radiosurgery) Plus Ipilimumab

Who this might be right for
Newly Diagnosed Melanoma Metastases in the Brain and Spine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Early research (Phase 1)Ended earlyNCT00667901
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
University of Medicine and Dentistry of New Jersey 15
Testing effectiveness (Phase 2)WithdrawnNCT02452281
What this trial is testing

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Rabih Said
Early research (Phase 1)Ended earlyNCT05501912
What this trial is testing

ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorBRAF V600 Mutation
ABM Therapeutics Shanghai Company Limited 20
Early research (Phase 1)Study completedNCT01191775
What this trial is testing

PNT2258 in Patients With Advanced Solid Tumors

Who this might be right for
CancerLymphomaProstate Cancer+1 more
Sierra Oncology LLC - a GSK company 22
Post-approval studies (Phase 4)UnknownNCT00540930
What this trial is testing

Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

Who this might be right for
Uveal MelanomaRadiation RetinopathyRadiation Maculopathy
Shields, Shields and Associates 400
Next Page